RBC Capital raises Corpay stock target to $400, maintains rating
RBC Capital Markets analyst Daniel Perlin updated the firm's outlook on Corpay shares, raising the price target to $400 from the previous $354, while maintaining a Sector Perform rating. The new ...
RBC Capital lifts Fiserv stock price target to $270 from $255
RBC Capital Markets maintained a positive outlook on Fiserv (NYSE:FI) shares, raising the price target to $270 from the previous $255, while keeping an Outperform rating on the stock. The adjustment ...
PepsiCo price target lowered to $164 from $172 at RBC Capital
RBC Capital lowered the firm’s price target on PepsiCo (PEP) to $164 from $172 and keeps a Sector Perform rating on the ...
Hologic price target lowered to $85 from $88 at RBC Capital
RBC Capital analyst Conor McNamara lowered the firm’s price target on Hologic (HOLX) to $85 from $88 and keeps a Sector Perform rating on the ...
FMC downgraded at RBC Capital; shares plunge on weak outlook
FMC (NYSE:FMC) on Wednesday was downgraded to Sector Perform from a previous investment rating of Outperform by analysts at ...
RBC Capital Keeps Their Sell Rating on Rational (0FRJ)
RBC Capital analyst Sebastian Kuenne maintained a Sell rating on Rational (0FRJ – Research Report) today and set a price target of €600.00. The ...
Energy & Utilities Roundup: Market Talk
Find insight on TotalEnergies, oil and natural gas futures, and more in the latest Market Talks covering Energy and Utilities ...
Sarepta could be down on patient death in FDA database, says RBC Capital
RBC Capital analyst Brian Abrahams says shares of Sarepta (SRPT) could be trading lower today on an FDA database update that ...
Biggest of the Big Six: How RBC opened a $100-billion market-cap gap over its banking rivals
While Royal Bank focused on dealmaking in the U.S., its biggest domestic rival, TD, embraced retail banking — a 'cutthroat' ...